Physician profile
Ting Chen
NPI 1861854945
$5,659.90
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $443 · 2021: $3,577 · 2022: $868 · 2023: $640 · 2024: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $771.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $771.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,233.59 | 2020-2024 | Therasphere Y90 Glass Microspheres 10 Gbq, Obsidio |
| Terumo Medical Corporation | $1,031.49 | 2021 | |
| Bard Peripheral Vascular, INC. | $902.98 | 2020-2021 | |
| Inari Medical, INC. | $779.74 | 2021-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $580.52 | 2021 | |
| W. L. Gore & Associates, INC. | $496.33 | 2021-2022 | |
| Penumbra, INC. | $289.99 | 2021-2023 | Ruby Coil |
| Cardiovascular Systems INC. | $125.87 | 2020 | |
| Abbott Laboratories | $105.36 | 2022 | |
| Argon Medical Devices, INC. | $58.63 | 2022 | |
| Covidien LP | $22.91 | 2020 | |
| Medtronic Vascular, INC. | $17.30 | 2020 | |
| Medtronic USA, INC. | $15.19 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ting Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.